Compare Impinj Inc (PI) vs UnitedHealth Group Inc (UNH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Impinj Inc vs UnitedHealth Group Inc — how do they compare? Impinj Inc trades at $137.27 (market cap $4.14B), while UnitedHealth Group Inc trades at $431 (market cap $396.27B). The key difference: UnitedHealth Group Inc is far larger — about 95.7× Impinj Inc's market cap, and UnitedHealth Group Inc pays a 2.13% dividend while Impinj Inc pays none. Which is the better fit depends on your goals.
| PI | UNH | |
|---|---|---|
Market Cap | $4.14B | $396.27B |
Sector | Technology | Health |
52-Week High | $241.91 | $436.35 |
52-Week Low | $91.34 | $237.77 |
Enterprise Value | $4.28B | $442.96B |
Dividend Yield | — | 2.13% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Impinj (PI) trades at $137.72, down 0.33% on the day, with technical indicators showing bearish momentum despite recent earnings beats. The company reported mixed Q1 2026 results with $0.14 EPS beating expectations but faces profitability challenges with negative net income margins. Analyst sentiment remains strongly positive with 73% buy ratings and a $167.50 consensus price target, representing 22% upside potential from current levels.
While analyst optimism and RFID market positioning provide upside potential, significant risks include persistent negative profitability, high valuation multiples, and recent insider selling. The stock's technical weakness near key support levels at $136-$135 suggests near-term caution despite long-term growth prospects in the expanding RFID market.
UnitedHealth Group (UNH) trades at $431.31, up 2.32% today, with a bullish technical outlook and strong analyst support. The stock shows consistent earnings beats, with Q2 2026 EPS of $6.38 surpassing expectations by 29%, and maintains robust cash flow from operations of $19.70 billion in 2025. Recent news highlights strategic moves to reduce pediatric prior authorizations, aiming to improve care access and operational efficiency.
The outlook remains positive with an 82.69% analyst buy rating and a consensus price target of $476.50, implying 10.5% upside. Key risks include regulatory scrutiny, as seen in Massachusetts' $100 million Medicaid fraud lawsuit filed May 29, 2026, and margin pressure from rising medical costs. Long-term growth is supported by aging demographics and digital health investments.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Impinj Inc
Impinj, Inc. is a leading provider of RAIN RFID (radio-frequency identification) solutions. The company's platform includes endpoints (tag chips), connectivity devices (readers and gateways), and software, enabling businesses to wirelessly identify, locate, and authenticate everyday items. Impinj's technology is crucial for applications in retail, supply chain management, healthcare, and logistics, helping businesses to automate inventory, track assets, and improve operational efficiency.
Read more on PI →About UnitedHealth Group Inc
UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Read more on UNH →
